(Q35952682)

11 August 2017

1 reference

title

Dopamine, depression and antidepressants (English)

1 reference

11 August 2017

4

Michel Bourin

1 reference

11 August 2017

1

Eric Dailly

1 reference

11 August 2017

Franck Chenu

2

1 reference

PubMed ID

15548230

11 August 2017

Caroline E Renard

series ordinal

3

1 reference

11 August 2017

1 December 2004

1 reference

Fundamental and Clinical Pharmacology

11 August 2017

1 reference

11 August 2017

18

1 reference

11 August 2017

601-607

1 reference

11 August 2017

6

1 reference

Dopamine receptors and brain function.

11 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00287.X

New insights into dopaminergic receptor function using antisense and genetically altered animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00287.X

Serotonin1b receptor stimulation enhances dopamine-mediated reinforcement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00287.X

Regulation of serotonin-facilitated dopamine release in vivo: the role of protein kinase A activating transduction mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00287.X

Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00287.X

Role of 5-HT(2C) receptors in the control of central dopamine function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00287.X

Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00287.X

What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00287.X

Is dopamine implicated in the antidepressant-like effects of selective serotonin reuptake inhibitors in the mouse forced swimming test?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00287.X

Brain-derived neurotrophic factor controls dopamine D3 receptor expression: implications for neurodevelopmental psychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00287.X

The effects of antidepressants and electroconvulsive shocks on the functioning of the mesolimbic dopaminergic system: a behavioral study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00287.X

Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00287.X

Adenosine A2A receptors and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00287.X

Tyrosine hydroxylase, aromatic L-amino acid decarboxylase and dopamine metabolism after chronic treatment with dopaminergic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00287.X

Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00287.X

The behavioural effects of pramipexole, a novel dopamine receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00287.X

10.1111/J.1472-8206.2004.00287.X

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15548230